Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Weight-Loss Drug Wegovy Cuts Heart Risk in New Study
Novo Nordisk’s anti-obesity drug reduced people’s risk of suffering heart attacks, strokes and cardiovascular deaths by 20%. Source link
Canada’s CPKC signs deal to study passenger rail project in Mexico By Reuters
© Reuters. MEXICO CITY (Reuters) – Mexico’s government and railroad company Canadian Pacific (NYSE:) Kansas City (CPKC) have formalized an agreement to study the viability
ChatGPT’s AI to power Chegg study buddy as educators wrestle with tech By Reuters
© Reuters. FILE PHOTO: ChatGPT logo is seen in this illustration taken March 31, 2023. REUTERS/Dado Ruvic/Illustration By Jeffrey Dastin (Reuters) – The artificial intelligence
US begins study of possible rules to regulate AI like ChatGPT By Reuters
© Reuters. FILE PHOTO: ChatGPT logo is seen in this illustration taken, February 3, 2023. REUTERS/Dado Ruvic/Illustration/File Photo By David Shepardson and Diane Bartz WASHINGTON
Australia to work with Germany on critical minerals study
Adds details on the collaboration, background April 6 (Reuters) – Australia will team up with Germany to create new opportunities for the study of critical
Bayer’s New American CEO to Study Wounded Pharma Giant Before Acting
Business Europe Bill Anderson aims to drive innovation and cultural change and lauds ‘compelling logic’ of Monsanto acquisition Source link
A Case Study on the Power of Business Model Innovation
While there are many forms of innovation that a company can develop – such as product, process, network and customer experience innovation – business model innovation is
U.S. labor force gap mostly due to pre-pandemic trends, study finds By Reuters
© Reuters. FILE PHOTO: People walk on a street in New York, U.S., November 14, 2022. REUTERS/Eduardo Munoz/File Photo By Howard Schneider WASHINGTON (Reuters) –
Biogen: BIIB080 Phase 1b Study Shows Reduction Of Tau PET Across Brain Regions
(RTTNews) – Biogen Inc. (BIIB) reported Phase 1b clinical data showing that the investigational antisense oligonucleotide therapy, BIIB080, reduced soluble tau protein in cerebrospinal fluid